Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
제약회사의 현금흐름이 연구개발투자에 미치는 영향 -코스닥시장을 중심으로Effect of Cash flow on the R&D investment of Pharmaceutical Companies - focused on KOSDAQ market
- Other Titles
- Effect of Cash flow on the R&D investment of Pharmaceutical Companies - focused on KOSDAQ market
- Issue Date
- 2015
- Publisher
- 한국콘텐츠학회
- Keywords
- Pharmaceutical Companies; R& D Investment; Cash Flow; Internal Finance; External Finance; 제약회사; 연구개발투자; 현금흐름; 내부금융; 외부금융
- Citation
- 한국콘텐츠학회 논문지, v.15, no.8, pp.473 - 480
- Indexed
- KCI
- Journal Title
- 한국콘텐츠학회 논문지
- Volume
- 15
- Number
- 8
- Start Page
- 473
- End Page
- 480
- ISSN
- 1598-4877
- Abstract
- The purpose of this study is to analyze the influence of the cash flow of pharmaceutical companies on R&D investment. 143 pharmaceutical companies listed in the KOSDAQ market from 2009 to 2013. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price was extracted from KISVALUE-Ⅲ of NICE Information Service Co., Ltd. STATA 12.0 was used as the statistical package for panel analysis. The summary of the findings and the interpretation of the significance of this are as follows: First, the current ratio (internal finance) had a positive influence on R&D investment. Second, the debt ratio (external finance) had a negative influence on R&D investment. The pharmaceutical company prefers internal funds to external funds due to the asymmetry of information in the loan markets. In other words, this shows why internal finances have a significant influence on R&D investment at pharmaceutical companies.
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.